Andersen–Tawil syndrome

Andersen–Tawil syndrome
This condition affects the QT interval(in blue)
Classification and external resources
Specialty	cardiology
ICD-10	I45.8
ICD-9-CM	426.82, 794.31
OMIM	170390
DiseasesDB	700
MeSH	D050030
GeneReviews	Andersen-Tawil syndrome

Andersen–Tawil syndrome, also called Andersen syndrome and Long QT syndrome 7, is a form of long QT syndrome.^[1] It is a rare genetic disorder, and is inherited in an autosomal dominant pattern and predisposes patients to cardiac arrhythmias. Jervell and Lange-Nielsen Syndrome is a similar disorder which is also associated with sensorineural hearing loss.

Symptoms

A triad of hypokalemic periodic paralysis, potentially fatal cardiac ventricular ectopy and characteristic physical features is known as Anderson-Tawil Syndrome. It affects the heart, symptoms are a disruption in the rhythm of the heart's lower chambers (ventricular arrhythmia) in addition to the symptoms of long QT syndrome. There are also physical abnormalities associated with Andersen–Tawil syndrome, these typically affect the head, face, and limbs. These features often include an unusually small lower jaw (micrognathia), low-set ears, and an abnormal curvature of the fingers called clinodactyly.

Diagnosis

• Prolongation of QT interval
• Cardiac arrhythmias
• Weakness: attacks or permanent

Type 1 and type 2

Cardiac muscle

Two types of Andersen–Tawil syndrome are distinguished by their genetic causes.

• Type 1, which accounts for about 60 percent of all cases of the disorder, is caused by mutations in the KCNJ2 gene.^[2][3][4]
• The remaining 40 percent of cases are designated as type 2; the cause of the condition in these cases is unknown.

The protein made by the KCNJ2 gene forms a channel that transports potassium ions into muscle cells. The movement of potassium ions through these channels is critical for maintaining the normal functions of skeletal muscles which are used for movement and cardiac muscle. Mutations in the KCNJ2 gene alter the usual structure and function of potassium channels or prevent the channels from being inserted correctly into the cell membrane. Many mutations prevent a molecule called PIP2 from binding to the channels and effectively regulating their activity. These changes disrupt the flow of potassium ions in skeletal and cardiac muscle, leading to the periodic paralysis and irregular heart rhythm characteristic of Andersen–Tawil syndrome.Researchers have not yet determined the role of the KCNJ2 gene in bone development, and it is not known how mutations in the gene lead to the developmental abnormalities often found in Andersen–Tawil syndrome.

Treatment

High dose of K+ has been used with different results.

Eponym

It is named for Ellen Andersen^[5] and Rabi Tawil.^[6][7]

References

• This article incorporates public domain text from The U.S. National Library of Medicine

External links

• OMIM entries on Anderson-Tawil syndrome
• Consortium for Clinical Investigation of Neurologic Channelopathies entry on Andersen-Tawil Syndrome (ATS)